These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9811167

  • 1. Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis.
    Hashimoto N, Kuro T, Taira S, Matsumura Y.
    J Pharm Pharmacol; 1998 Sep; 50(9):1051-8. PubMed ID: 9811167
    [Abstract] [Full Text] [Related]

  • 2. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Eur J Pharmacol; 1995 Jul 14; 280(3):311-6. PubMed ID: 8566099
    [Abstract] [Full Text] [Related]

  • 3. Effects of FR139317 on renal responses to acute nitric oxide blockade in anaesthetized rats.
    Matsumura Y, Kuro T, Hashimoto N, Taira S.
    Clin Exp Pharmacol Physiol; 1998 Jun 14; 25(6):441-4. PubMed ID: 9673820
    [Abstract] [Full Text] [Related]

  • 4. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
    Matsumura Y, Hashimoto N, Fujita K, Morimoto S.
    Eur J Pharmacol; 1997 Jan 14; 319(1):65-9. PubMed ID: 9030899
    [Abstract] [Full Text] [Related]

  • 5. Renal effects of endothelin in anesthetized rabbits.
    Ono N, Matsui T, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S.
    Eur J Pharmacol; 1998 Oct 23; 359(2-3):177-84. PubMed ID: 9832389
    [Abstract] [Full Text] [Related]

  • 6. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
    Matsuura T, Miura K, Ebara T, Yukimura T, Yamanaka S, Kim S, Iwao H.
    Br J Pharmacol; 1997 Sep 23; 122(1):81-6. PubMed ID: 9298531
    [Abstract] [Full Text] [Related]

  • 7. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
    Hashimoto N, Kuro T, Fujita K, Azuma S, Matsumura Y.
    Biol Pharm Bull; 1998 Aug 23; 21(8):800-4. PubMed ID: 9743245
    [Abstract] [Full Text] [Related]

  • 8. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Aug 23; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 9. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
    Gardiner SM, Kemp PA, March JE, Bennett T, Davenport AP, Edvinsson L.
    Br J Pharmacol; 1994 Jun 23; 112(2):477-86. PubMed ID: 8075866
    [Abstract] [Full Text] [Related]

  • 10. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Jpn J Pharmacol; 1996 Apr 23; 70(4):313-9. PubMed ID: 8774759
    [Abstract] [Full Text] [Related]

  • 11. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD, Friberg P, Adams MA.
    J Hypertens; 1996 Aug 23; 14(8):975-81. PubMed ID: 8884552
    [Abstract] [Full Text] [Related]

  • 12. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
    Gellai M, De Wolf R, Fletcher T, Nambi P.
    Pharmacology; 1997 Dec 23; 55(6):299-308. PubMed ID: 9413859
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Do ETA receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade?
    Fujihara CK, De Nucci G, Zatz R.
    J Cardiovasc Pharmacol; 1995 Dec 23; 26 Suppl 3():S462-5. PubMed ID: 8587446
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of nitric oxide in endothelin ETB receptor-mediated inhibitory actions on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
    Matsuo G, Matsumura Y, Tadano K, Hashimoto T, Morimoto S.
    J Cardiovasc Pharmacol; 1997 Sep 23; 30(3):325-31. PubMed ID: 9300316
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist.
    Yamamoto T, Shimoyama N, Asano H, Mizuguchi T.
    J Pharmacol Exp Ther; 1994 Oct 23; 271(1):156-63. PubMed ID: 7965709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.